Skip to main content
TipRanks
Go Ultimate75% OFF

Jason Lettmann Insider Profile

11 Followers

Jason Lettmann, CEO, Director at ALX Oncology Holdings, holds 294.38K shares in ALX Oncology Holdings (Ticker: ALXO).

Jason Lettmann's Trading History

ALXO
ALX Oncology Holdings
Aug 18, 2026CEO, DirectorUninformative Sell4.30K$295.85K
ALXO
Insider Shares: 294.38K (0.21%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 18, 2026Uninformative Sell$4.30K2,230$1.93―
Mar 23, 2026Informative Sell$26.71K12,311$2.17+52.70%
Feb 19, 2026Uninformative Sell$5.00K2,201$2.27―
Sep 18, 2025Informative Buy$99.19K92,233$1.07+101.80%
Aug 19, 2025Uninformative Sell$1.52K2,382$0.64―

You May Also Like

Jason Lettmann insider profile FAQ

What is the percentage of profitable transactions made by Jason Lettmann?
The percentage of profitable transactions made by Jason Lettmann is 83%.
What is the average return per transaction made by Jason Lettmann?
The average return per transaction made by Jason Lettmann is 45.60%.
What stocks does Jason Lettmann hold?
Jason Lettmann holds: ALXO stocks.
What was Jason Lettmann’s latest transaction?
Jason Lettmann’s latest transaction was an Uninformative Sell of $4.30K.
What was Jason Lettmann's most profitable transaction?
Jason Lettmann’s most profitable transaction was an Informative Buy of ALXO stock on September 18, 2025. The return on the trade was 101.80%.
What is Jason Lettmann's role in ALX Oncology Holdings?
Jason Lettmann's role in ALX Oncology Holdings is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.